A persistent infection with varicella-zoster virus was established in the Mewo human melanoma cell line. This persistently infected cell line went through periodic crises of virus-induced cell killing and then recovery. Analyses of viral DNA derived from the persistently infected cultures revealed that novel viral nucleic acid rearrangements had been generated. These viral DNA sequences were derived from a specific region of the inverted repeat sequence of the genome flanking the short unique genome segment. The novel DNA was of various lengths, each generated by tandem duplication of an approximately 2760 base pair sub-sequence of the normal viral inverted repeat. These novel sequences were inserted into an otherwise apparently normal genome.
INTRODUCTION
Persistent infection of cultured cells has been observed for most viruses (Youngner & Preble, 1980) including the normally lytic herpesviruses, herpes simplex virus (HSV) (Robey et al., 1976; Doller et al., 1979; Cummings et al., 1981; Biswal et al., 1983) , equine herpesvirus (EHV) (Dauenhauer et al., 1982) , bovine herpesvirus (Michalski & Hsiung, 1976) , cytomegalovirus (Mocarski & Stinski, 1979; Staczek et al., 1984; Ogura et al., 1986) and varicella-zoster virus (VZV) (Perez Martin et al., 1986) . Defective-virus is frequently associated with persistent infections. This has been particularly noted in RNA viruses, but defective viral genomes have also been reported in persistent EHV infections (Dauenhauer et al., 1982; Baumann et al., 1986) . Defective viral genomes can also arise independently of persistent infection, for example during high multiplicity passaging (Huang & Baltimore, 1977; Barrett & Dimmock, 1986) . Such defective viral genomes have been found for many herpesviruses (reviewed by Frenkel, 1981) , including VZV (Vlazny & Hyman, 1985) . Defective herpesvirus genomes generally consist of multiple tandem duplications of an origin of DNA replication and cleavage/encapsidation sequences from the genome termini, with much of the remaining genome deleted (Vlazny & Frenkel, 1981 ; Schr6der et al., 1984; Mocarski et al., 1985; Vlazny & Hyman, 1985; Baumann et al., 1986; Wu et al., 1986) .
Persistent infections allow virus and cell to coexist for prolonged periods without complete cell destruction or loss of virus. This coexistence is somewhat reminiscent of viral latency, although herpesvirus latency involves expression of a much reduced and unusual subset of viral functions (Galloway et al., 1982; Rock et al., 1986; Deatly et al., 1987; Puga & Notkins, 1987; Stevens et al., 1987 ) while persistence involves a reduced level of expression of most or all normal viral functions. However, since the mechanism of development of latency is presently unclear, greater understanding of any virus-cell interaction which allows long-term survival of both cell and virus may provide information helpful in understanding how herpesviruses can enter into a latent state in humans. We therefore characterized the viral genome present in a line of cells 0000-8297 © 1988 SGM Laboratories). The coverslips were rinsed with PBS, mounted in glycerol :PBS (9:1), and viewed with a Leitz Dialux 20 fluorescence microscope (E. Leitz, Rockleigh, N.J., U.S.A.). Photography was on Kodak Plus X film.
Plaque isolation. Cell-free VZV was prepared from the persistently infected cells which exhibited cytopathology (Mewo-EF-2, passage 9) using the methods of Grose et al. (1979) . Appropriate dilutions of cell-free virus were plated on confluent uninfected Flow 5000 cells. After a 2 h adsorption period, the ceils were ovedaid with nutrient agar made by mixing equal volumes of 2 % purified agar (Difco) with a double concentration of normal cell growth medium. The cells were maintained for 14 days at 37 °C in the CO 2 incubator and were fed on days 5 and 10. On day 14, the cells were stained by the addition of neutral red to a final concentration of 1:30000 to visualize the plaques (Hsiung & Fong, 1982) . Individual plaques were picked using sterile Pasteur pipettes.
RESULTS

Origin of persistent infection
When the Mewo human melanoma cell line was infected with the EF strain of VZV, the vast majority of the infected cells died and detached from the tissue culture flask within 5 to 10 days of infection. A few survivors appeared unaffected by the virus infection. These survivors slowly grew, and with regular refeeding became nearly confluent over a period of several weeks. As they approached confluence a VZV-like cytopathology again appeared. The majority of cells died and the survivors grew as before. This cycling of cell death and regrowth occurred with no obvious periodicity. An example of this cycling appears later in this report (Fig. 4) . The resulting cell line was designated Mewo-EF-2.
Viral antigen expression
Cells in a passage 3 Mewo-EF-2 culture which showed very little microscopically visible cytopatho!ogy were fixed, treated with human serum containing antibodies to VZV, rinsed, and incubated with fluorescein-conjugated anti-human IgG. After rinsing, the cells were viewed under a fluorescence microscope. The same procedures were carried out with control ceils. The results are shown in Fig. 1 . The persistently infected cells treated with the VZV antibodypositive serum showed some localized loci of intense fluorescence (Fig. 1 a) , while the replicate cells treated with human serum lacking VZV antibody were uniformly negative (Fig. 1 b) . Controls consisting of acutely infected Mewo cells treated with the VZV antibody-positive serum (Fig. I c) or the VZV antibody-negative serum (Fig. 1 d) were entirely positive or negative, respectively. Uninfected Mewo cells treated with the VZV antibody-positive serum (Fig. 1 e) or the antibody-negative serum (Fig. l f) showed no evidence of fluorescence. Therefore, even when no microscopically visible cytopathology was observed, some of the cells in the persistently infected cultures produced viral antigen at levels as high as productively infected cells.
Analysis of virus from persistently infected cells
At various times after establishment, the Mewo-EF-2 cell cultures were labelled with 32po4, and viral nucleocapsid DNA was purified 40 to 48 h later. These labelled DNAs were digested with BamHI and the resulting fragments were separated by agarose gel electrophoresis. In other cases, unlabeUed Mewo-EF-2 DNA was digested with BamHI and examined by Southern blot hybridization using 32p-labelled whole VZV DNA as the probe. Autoradiograms of some of these gels are shown in Fig. 2 . The expected BamHI fragments were present, as well as at least two visible novel fragments (labelled 1 and 3; fragment B/2 indicates another novel fragment that comigrates with B). Thus, the virus involved in the persistent infection appears to have undergone some alteration during the generation of the persistent infection or, alternatively, to have enriched a pre-existing minor viral variant.
To examine the nature of the persistent infection and the novel DNA in more detail, virus was plaque-purified from the persistently infected cells. Plaques were isolated from monolayers of human embryo cells which had been infected with cell-free virus produced by sonication of Mewo-EF-2 cells. The results of these experiments (Fig. 3) showed that seven of the 10 plaques that had been isolated contained virus with novel fragments (by restriction endonuclease pattern), while the parental EF virus restriction fragment pattern was found in the remaining isolates. It is important to note that due to the nature of VZV replication in vitro the plaques in many cases undoubtedly originated from more than a single virion. Previous experiments (Dohner et al., 1988) showed that at least 2 0~ of plaque isolates began with more than one virion, and the actual percentage was probably even higher since there was no method for determining what percentage of apparently clonal isolates actually originated from multiple identical virions. Similarly, in the experiment reported here, it was not possible to determine how many of the novel fragment-containing isolates were non-clonal in origin. Nevertheless, the fact that seven of the 10 isolates contained novel fragments suggests that a high percentage of the virions present in the Mewo-EF-2 culture from which the cell-free virions were obtained contained the novel D N A . Control experiments (not shown) in which plaques were isolated from the EF parent showed that none of the parental virus plaques (of 73 plaques tested) had these novel fragments. However, 11 of the 73 plaque isolates showed evidence of some additional fragments that were different from the novel fragments shown here, but whose nature has not been determined. Growth tests on human embryo cells showed no apparent growth advantage or disadvantage for the novel fragment-carrying, plaque-purified virus isolates. Furthermore, the novel fragments appeared to be a stable part of the genome, at least over four passages in human embryo cells, and for at least 12 passages of the Mewo-EF-2 cells (data not shown). When the novel fragment-containing plaque isolates were grown on uninfected Mewo cells the infection could not be distinguished from infection by the normal EF strain. However, when the cells were left to recover from the infection (i.e. to generate new persistent infections), those cells infected 
ii ili IIII i i ! Fig. 3 . BamHI restriction fragment patterns of viral nucleocapsid DNA produced by plaques isolated from Mewo-EF-2 passage 9 ceils. Nucleocapsid DNA was purified from human embryo cells infected with the plaque isolates. All were at passage 3 except plaque 8 which was at passage 4. EF is the noncloned EF parent. with virus from novel fragment-containing plaques (plaques 3 and 6 in Fig. 3 ) showed slightly faster recovery and regrowth (Fig. 4 d, b , cell lines 3-1 and 6-1) compared with cells infected with virus from plaques (plaques 5 a n d 7 in Fig. 3 ) not having novel fragments or the original E F strain ( Fig. 4c , a, e, cell lines 5-1 and 7-1 or EF). This is especially apparent after the first subculturing (passage 2 to passage 3). The slight difference between cultures initiated with isolates containing and isolates not containing novel fragments continued to be apparent by the greater number of days that elapsed before a culture more than 25 ~o confluent succumbed to a renewed round of viral replication and cell destruction. However, the differences between these persistently infected cell lines was never more significant than shown in Fig. 4 , even though time in culture continued to 229 days.
Analysis of viral DNA from the persistently infected cell line In Fig. 2 there was a barely visible reduction in the intensity of the BamHI fragment J band in the virus from Mewo-EF-2 cells. In Fig. 3 , those plaque isolates which contained novel fragments appeared to have only half the normal amount of the BamHI J fragment (by visual estimation). These observations suggested that the novel fragments may have some relationship with the BamHI J fragment.
A series of Southern blot hybridizations were performed to determine which part of the viral genome gave rise to the novel BamHI fragments. Each of the cloned BamHI fragments of EF VZV DNA was labelled with 32p by nick translation and hybridized with Southern blots of paired BamHI digests of non-radioactive EF and Mewo-EF-2 nucleocapsid DNA. Part of these hybridizations is shown in Fig. 5 . Each of the cloned fragment probes hybridized with the same fragments in EF as in Mewo-EF-2 DNA except for the BamHI J fragment (lanes 3 and 4 respectively). The J fragment probe hybridized, as expected, with the J fragment in the EF lane, but in the Mewo-EF-2 lane the probe hybridized with the J fragment as well as with a series of larger fragments beginning with those novel fragments seen in Fig. 2 . These novel fragments were labelled starting with the smallest as 1 (N 1), the next largest (comigrating with BamHI B) as N2, then N3, N4, N5 etc. The hybridizations shown in the autoradiographs in Fig. 5 include as probes the cloned BarnHI fragment J (lanes 3 and 4) b.nd the cloned BamHI fragments B (lanes 1 and 2), K (lanes 7 and 8), R (lanes 9 and 10) (Mishra et al., 1984; Ruyechan et al., 1985) , and c (lanes 5 and 6) (unpublished data) which map adjacent to J (see Fig. 9 ).
The novel fragments contain sequences with homology to a single region of the inverted repeat segment of the viral geriome. A portion of an analogous region of the viral DNA is present as multiple copies in defective genomes of other herpesviruses (Frenkel, 1981; Vlazny & Frenkel, 1981; Schrfder et al., 1984; Mocarski et al., 1985; Baumann et al., 1986; Wu et al., 1986) , and is also present in defective and abnormal DNA forms found in the Oka vaccine strain of VZV (Vlazny & Hyman, 1985) . These novel DNA fragments could represent defective viral DNA encapsidated in the normal manner. Experiments were then performed to determine whether the novel fragments were attached to an apparently normal genome and, if so, whether replacement ofBamHI J with a novel fragment could occur in either inverted repeat of the DNA molecule. EF and Mewo-EF-2 nucleocapsid DNAs were digested individually with restriction endonucleases which cleave VZV DNA within the Us and UL regions, but not within the IRs or TRs regions. Such cleavages produce fragments which include one BamHI J fragment in a terminal fragment and a second BamHI J fragment in an internal fragment. Because of the inversion of the viral IRs-Us-TRs genome segment, two unique internal fragments and two unique terminal fragments are produced by such cleavages (Dumas et al., 1981; Ecker & Hyman, 1982; Straus et al., 1981 Straus et al., , 1982 Davison & Scott, 1983; Mishra et al., 1984) . Half of the molecules have one internal/terminal pair and half have the other pair. Three enzymes, BgllI, EcoRI and XbaI, which met the criteria specified above, were used. In a mixed population of normal and novel genomes, if the novel fragments were present in each inverted repeat of an otherwise normal genome, the restriction fragments found after digestion with these enzymes should include the normal four fragments containing the BamHI J fragment as well as a series of new fragments whose sizes differ in increments of the size difference between BamHI fragment J and the novel fragment.
The digestions were performed, the resulting fragments were separated by agarose gel electrophoresis, transferred to a nylon membrane and then hybridized with 32p-labelled cloned BamHI J fragment. Fig. 6 shows the autoradiograph of one of the hybridized blots and Table 1 shows the calculated fragment sizes. The sizes of the fragments produced by BamHI digestion of the Mewo-EF-2 DNA (Fig. 6, lane 2) suggested that the novel fragments were produced by a repetition of approximately 2815 + 208 bp (determined from the size differences between BamHI J and successive novel BamHI fragments). These data were then analysed to determine whether the prediction that the novel fragments can occur in either TRs or IRs was valid. Due to increasing error in fragment size estimation with increasing fragment size, and to the decreasing intensity of the larger novel fragments, only predicted fragments having one, two or three incremental repeats were examined. Table 2 shows actual fragment sizes from Table 1 adjacent to fragment sizes predicted from the four fragments found in both EF and Mewo-EF-2 DNA digests. For example, when the 8000 bp EcoRI J fragment had an increment of 2815 bp, fragments of 10815, 13630 and 16445 bps were predicted. These correspond well with fragments of 10 834, 13 893 and 16 990 (comigrating with EcoRI fragment A) bp found on the gel. When the 12241 bp EcoRI F fragment was increased by 2815 bp, fragments of 15056, 17871 and 20686 bps were predicted. These correspond to the fragments 15196, 18120 and either 19836 or 21476 bp found on the gel. Likewise, when the 12731 bp EcoRI E fragment contained an increment, the predicted fragments of 15 546, 18 361 and 21 176 bp corresponded well with the 15 726, 18 408 and 21476 bp fragments found on the gel. And, finally the predicted fragments derived from an increment of the EcoRI A fragment (19 805, 22 620 and 25 435 bp) corresponded with the fragments of 19836 and 23228 bp resolved on the gel. Similar results were found upon analysis of the fragments produced by BglII and XbaI. These data show that the novel fragments can replace either of the normal BamHI J fragments, and probably replace both normal BamHI t Mean fragment sizes were determined from three measurements on a 0.5~ agarose gel run for 21 h at 60 V and three measurements on a 0-65~ agarose gel run for 40 h at 60 V. Exceptions were: (i) EF + BamHI fragments were run in two lanes on each gel so that six measurements were made on each gel; (ii) Mewo-EF-2 + BgllI fragments 8 and 9 were measured only on the 0.5~ gel.
J fragments in many of the genomes. These experiments, and the BamHI digestions, also demonstrate that the novel fragments are inserted into otherwise apparently normal genomes. Because of our inability to be certain that plaque isolates (Fig. 3) were actually clonal, we could not determine whether a genome exists stably in a form containing only the novel tandem repeats. The fact that all of the isolates contained the normal BamHI J fragment suggests that genomes containing the novel fragment either frequently revert to the normal form, or often consist of one normal and one novel repeat.
In order to analyse the novel fragments in more detail, the three smallest novel BamHI fragments (N1, N2 and N3), as well as the BamHI J fragment from Mewo-EF-2 nucleocapsid DNA were purified from agarose gels and cloned into the BamHI site of pBR322. The previously described (Mishra et al., 1984) BamHI fragment J clone from strain EF was used as the reference BamHI J DNA in these experiments. The plasmid DNAs were digested with BamHI to free the cloned fragments (N1, N2, N3 and J) from the vector. Agarose gel electrophoresis showed that each cloned fragment corresponded in size to the original novel or J fragments found in BamHI digests of Mewo-EF-2 nucleocapsid DNA (not shown).
These fragments were then digested with either Sail or XhoI, separated by agarose gel b -- i" Predicted fragment was larger than any fragment clearly observed on gels.
electrophoresis, and transferred to a nylon membrane for hybridization analysis. The blots were hybridized with ~2P-labelled cloned EF VZV BamHI J fragment DNA. These l~ybridizations (Fig. 7) show first that many of the restriction fragments produced from the novel fragments are very similar, if not identical, to the restriction fragments derived from the BamHI J fragment. Second, they show that the BamHI J fragments cloned from the Mewo-EF-2 cells are, in all but one case, identical to the J fragment cloned from the parental EF strain. Third, they show that the fragments unique to the novel fragments have homology to the J fragment while at the same time appearing almost identical for each of the novel fragments. Each fragment seen in Fig. 7 was also detected in the ethidium bromide-stained gel, and no additional fragments were seen (data not shown). These data suggest that the novel fragments are a modified form of the normal BamHI J fragment sequence. The relationship of the novel fragments to the normal BamHI J fragment was analysed in more detail by producing restriction endonuclease cleavage maps for the BamHI J fragment and the three smallest BamHI novel fragments. The restriction endonucleases chosen for this mapping study were those which had previously been shown to cleave within the BamHI J fragment: BglI, HindlII, HpaI, KpnI, SalI, SaclI (SstlI) , SmaI and XhoI (Mishra et al., 1984) . The fragments chosen for analysis were the original BamHI J fragment from strain EF (done LT-2J), N1 (clone MEF2-3-cl3), N2 (clone MEF2-2-cl2) and N3 (clone MEF2-1-cll0). The recombinant plasmid DNAs were digested with BamHI to free the cloned fragments (J, N 1, N2 and N3) from the vector and each cloned fragment was purified by agarose gel electrophoresis.
First, the sub-fragments produced from each of the BamHI fragments (J, N1, N2 and N3) by each enzyme were determined by complete digestion with each of the eight restriction endonucleases followed by agarose gel electrophoresis and 'photography of the ethidium bromide-stained fragments under u.v. illumination..Fragment sizes were estimated by comparison with the migration of DNA fragments of known size on the same gel. Second, each DNA was end-labelled with 32p and digested with an enzyme (HindlII) that cleaved at only a single site in each of the four DNAs. The two HindIII subfragments derived from each of these BamHI DNA fragments were separated by agarose gel electrophoresis, electrophoretically eluted from the gel and purified.
A portion of each HindIII subfragment was completely digested with each of the remaining enzymes to determine the 32p-labelled end fragment, and a second portion of each DNA was partially digested with these enzymes to determine the order in which the additional fragments attach to the 32p-labelled end fragment. Finally, the maps produced for each pair of HindlII subfragments were joined to produce the complete restriction endonuclease cleavage map. The partial digestions for each DNA and each enzyme are shown in Fig. 8 . The fragments labelled with an asterisk are the terminal 32p-labelled fragments determined from the complete digestion. The fragments labelled a in the KpnI digest of the large HindlII subfragment originate in the R4 reiteration (Davison & Scott, 1986) . Each repeat in R4 has a KpnI site; thus the a fragments appear relatively indistinct because they actually consist of a series of partial digestion products having increments of 27 bp. The size of the R4 repeat measured in the KpnI partial digestions (Table 3 ) ranged from about 90 to 170 bp. Tandem repeated sequences such as the R4 reiteration are known to undergo deletion or duplication during replication in E. coli (Farabaugh et al., 1978) and such alterations must be responsible for at least some of the variations in sizes found in KpnI fragments derived from the R4 repeat in the cloned fragments. It is not known whether such heterogeneity was also present in the viral genomes. Certain fragments which appear in these autoradiographs labelled with a question mark were apparently artefacts and were not used in the maps. Most of these unused fragments appear in the large HindlII fragment digestions, but some also occur in the small HindlII fragment digestions. These fragments, usually less intense than others, were found reproducibly using two different preparations of the cloned DNAs and with several variations in the partial digestion conditions. We based our decision not to include these fragments in the map on the fact that fragments predicted to occur in the complete digestion of the cloned DNA, if the unused fragments were real, were not found when digestion products of the unlabelled DNAs were separated on agarose gels and stained with ethidium bromide. We are not certain of the origin of these fragments. They may represent a fraction of the cloned fragments which have been altered during replication in E. coll. Certain palindromic DNAs are reported to suffer deletion (Collins, 1981) , and deletion or insertion of copies of tandemly repeated sequences also occurs during DNA replication of E. coli (Farabaugh et al., 1978) . Each of the DNA fragments cloned in this study contain the region of the VZV genome that includes the 31 base palindrome in the origin of Fig. 8 . Partial digestion products of the HindIII subfragments of the BamHI fragments J, N1, N2 and N3 cleaved with BglI, Hpal, KpnI, SalI, SaeII, Sinai and XhoI. The DNAs were prepared and digested as described in Methods. The partial digestion products were separated by agarose gel electrophoresis on both 0.8% and 1.4% gels (only 0.8% or 1.4% shown, depending on fragment size). Marker DNAs used for size estimation were lambda BstEII, lambda SmaI and EF VZV BamHI fragments. (a) Small HindIII subfragments. (b) Large HindIII subfragments. The enzyme used is indicated above each group of lanes. Individual lane labels indicate fragment as follows: N3, 3; N2, 2; N 1, 1 ; fragment J, J. The band labelled with an asterisk is the 32p-labelled terminal fragment for each digest. Bands in the KpnI digests labelled a are a series of fragments generated by the multiple KpnI sites in the R4 reiteration (Davison & Scott, 1986) . Only the series closest to the 32p-labelled end can be distinguished from the nearby fragment. Fragments labelled with a question mark are fragments which were reproducibly present, usually less intense than other fragments, and which are presumed to be artefacts since the sizes of fragments they represented were not found in the complete digestions stained with ethidium bromide. Agarose gel percentage and autoradiographic exposure times were as follows. (a VZV DNA replication as well as several other palindromes of 10 to 13 bases, and the R4 tandem repeats (Davison & Scott, 1986) . Molecules altered during replication in E. coli could be a minor species producing fragments of altered size when digested with certain restriction enzymes, thus accounting for the unused partial digestion products. Alternatively, they may represent a digestion product produced only under the conditions used in the partial digestions i.e. low levels of enzyme, low levels of 32p-labeUed cloned DNA and high levels of bacteriophage lambda DNA carrier. They may, however, represent a minor DNA component which is disproportionately labelled during the end-labelling reaction and thus not detected in the ethidium bromidestained gels. The first possibility seems the most likely. Table 3 shows the number of bp calculated from the data in Fig. 8 for each restriction fragment within the HindlII subfragments. The fragments for each enzyme are shown in the same orientation in the table as they appear in the map shown in Fig. 9 . These maps are drawn with the orientation of the BamHI J fragment in the IRs genome segment.
Examination of these data showed that the short HindlII subfragments (the left side of the maps) derived from J and each of the three novel fragments were identical. Previous data (Fig.  7) showed that the novel fragments are composed entirely of sequences derived from the BamHI J fragment. Therefore, the long HindlII subfragments of the novel fragments must have been generated by extension or rearrangement of the BamHI J fragment sequences. Examination of the long HindlII subfragment portion of the maps showed that each of the DNAs had the same pattern of restriction enzyme cleavage sites at the left end of the subfragment, and, similarly, each DNA had the same pattern of restriction enzyme cleavage sites at the right end of the subfragment. Each novel fragment thus appears to be an extension of the next smaller size fragment by duplication of a portion of its internal sequence. These maps can be generated from the map of the BamHI J fragment by tandem duplication of an approximately 2760 bp segment of the genome beginning about 50 bp to the right of the HindlII site and extending to about 50 bp from the right end of the J fragment. Fragment J has one copy of this segment of the VZV genome, N1 has two copies, N2 has three copies and N3 has four copies. The tandem repeat is shown in Fig. 9 as the boxed portion of the maps of fragments J, N1, N2 and N3.
DISCUSSION
The experiments described in this paper have demonstrated that altered VZV DNA sequences found in persistently infected Mewo-EF-2 cells were encapsidated and part of an otherwise apparently normal genome. The novel DNA fragments were shown by hybridization and restriction endonuclease cleavage site mapping to be the result of tandem duplication of an approximately 2760 bp subsequence of the viral inverted repeat sequence. The tandem duplication encompassed a region of the VZV genome beginning about 50 bp to the right of the HindlII site in the IRs BamHI J fragment and ending about 50 bp before the BamHI fragments J and c junction. We examined this region using the VZV DNA sequence data ofDavison & Scott (1986) . Comparison of the restriction fragment map for the normal EF VZV genome in Fig. 9 with restriction fragment maps generated from the sequence data showed that the map locations were the same and that the fragment size estimations agreed within the limits of error of estimating fragment sizes from gels. Therefore, for this part of the genome, the EF strain and the strain sequenced by Davison & Scott (1986) are very similar, and comparison of features in the VZV sequence with our data are valid.
The region involved in the novel tandem repeats is located from approximately 108770 bp (50 bp from the HindlII site at 108 720 bp) to approximately 111527 bp (50 bp from the BamHI site at 111577bp) in the IR s genome segment, or from approximately 121122bp to approximately 118 365 bp in the TRs genome segment. The features located within this region by Davison & Scott (1986) are the G + C-rich R4 reiteration, the open reading frame for all of the 30K protein 63, a small part of the open reading frame for the 140K protein 62, and an origin of DNA replication.
Since the novel fragments duplicate an origin of replication, our initial hypothesis was that the novel fragments were from defective genomes which are known to contain tandem repeats of an origin of replication. However, this hypothesis was eliminated when the BgllI, EcoRI and XbaI BamHI fragments J, N1, N2 and N3, These maps were generated from the data in Table 3 , and are drawn in the digests showed that the novel fragments were part of otherwise apparently normal genomes. Extension in length of an otherwise normal herpesvirus genome similar to those having the novel fragments found here has been reported before. However, in each case the extended genomes were a minor fraction of the viral population. Vlazny & Hyman (1985) reported extended genomes similar to these as well as the typical form of defective genomes in the Oka vaccine strain of VZV. Their extended genome, however, involved a larger repeat length than the 2760 bp reported here, and their repeat also involved some sequences from the Us region. Umene & Enquist (1985) reported tandem duplications in two of 30 plaque isolates from HSV-1. The repeat lengths in these two isolates were 3100 bp and 3500 bp. These tandem duplications appear to be very similar in size to the novel repeats reported in this paper, although in the Mewo-EF-2 cell line the novel genomes were present in about a 10-fold higher percentage of plaque isolates than the novel genomes in the HSV-1 system. These reports and that of Knipe et al. (1978) indicate that herpesvirus virions can accommodate a genome at least 12.6 kb larger than normal. Some of the genomes in this report may be more than 20 kb larger than normal if each inverted repeat has four or more of the tandem repeats, as might be the case for genomes carrying N4 or larger novel fragments. However, the most abundant novel fragment (N1) contained just a single tandem repeat. It is possible that viral replication or encapsidation of the viral genome is less efficient when larger numbers of tandem repeats are present. The tandem repeats reported by Umene & Enquist (1985) contained an origin of replication and the sequence responsible for transcribing immediate early mRNA 5. Unlike the novel tandem repeats reported here, most of the sequence in the HSV-1 novel tandem repeat came from the Us region outside the short inverted repeat. Several recent reports (Davison & McGeoch, 1986; Felser et al., 1987; Stow & Davison, 1986) have shown that there is an underlying similarity between VZV and HSV in terms of gene coding regions, protein sequence homology and protein function. Davison & Scott (1986) report that protein 63 has amino acid sequence homology to HSV-1 protein IE68. The promoter and most of the 5' non-coding region of IE68 lie in the TRs segment, but the entire coding region is in the Us segment (McGeoch et al., 1985) . Examination of several HSV-1 references (Davison & McGeoch, 1986; McGeoch et al., 1985; Umene & Enquist, 1985) shows that the terms IE68 and IE mRNA 5 refer to the same gene. The novel tandem repeat reported by Umene & Enquist (1985) therefore was a repeat of a section of genome which was functionally the same as the section of genome found in the Mewo-EF-2-derived novel tandem repeat: an origin of DNA replication plus an immediate early protein coding region.
At this point we do not know whether the novel tandem duplication which has occurred in both HSV-1 and VZV is due to similar DNA sequences that promote a recombination event giving rise to the tandem repetition, or whether it is due to some selective advantage possessed by genomes containing such repetitions. Since the genomes containing the tandem duplication were apparently greatly amplified in the Mewo-EF-2 cell line there is probably a selective advantage for the tandem duplication in the persistently infected cell line. Further analysis will be required to determine the function of the tandem repeats in acute and persistent infection as well as to determine the recombination event that generated the tandem repeat, and whether the sequence involved in the recombination was similar to that reported by Umene & Enquist (1985) in HSV-1. Novel tandem duplications such as these may be intermediates in the generation of independent defective genomes. These tandem duplications could presumably act as defective genomes if the tandem repeats were bracketed by the sequences at the end of the genome which are responsible for cleavage of the concatemeric replication intermediates into unit length genomes and subsequent encapsidation. Determination of whether the repeated sequences reported by Vlazny & Hyman (1985) in the Oka vaccine strain of VZV are produced similarly to those reported in this paper will also be important, since that analysis may point to a difference between the vaccine strain and wild-type VZV strains.
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